Search Kisunla™ (type in keywords)
Search Medical Information
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Kisunla ™ (donanemab-azbt) injection, for intravenous infusion
350 mg/20 mL (17.5 mg/mL)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
VIDEO: Alzheimer's Disease: Understanding Donanemab
The video below describes donanemab and how it works in early symptomatic Alzheimer’s disease.
Date of Last Review: January 02, 2025
Document Number: VV-MED-141979
Are you satisfied with this content?